EPIX,ESSA Pharma Inc. | Healthcare

Healthcare

EPIX

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

ESSA Pharma Inc.EPIX

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.

The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer.

It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Latest News >

AbbVie to Book $3.5 Billion Impairment Charge Related to Potential Antipsychotic Drug Emraclidine

Jan 10, 2025

08:59 AM EST, 01/10/2025 (MT Newswires) -- AbbVie ( ABBV ) said in a regulatory filing Friday that it will book a non-cash after-tax intangible asset impairment charge of about $3.5 billion related to its potential schizophrenia drug emraclidine, acquired as part of its Cerevel Therapeutics buyout. The company said in November that phase 2 tests of emraclidine as a...

Sports streaming service Venu scrapped before it even launches

Jan 10, 2025

(Reuters) - Walt Disney ( DIS ), Fox and Warner Bros Discovery ( WBD ) on Friday abandoned plans to launch Venu Sports, their live sports joint venture, pulling the plug on a much-heralded effort that ran into substantial legal opposition. Shares of Warner Bros Discovery ( WBD ) and Fox fell more than 1%, while FuboTV's ( FUBO )...

Oil Up Nearly 4% on Report U.S. is Poised to Tighten Sanctions on Russia's Oil Industry

Jan 10, 2025

08:57 AM EST, 01/10/2025 (MT Newswires) -- Oil prices surged to a three-month high early on Friday following reports the outgoing Biden Administration is readying additional sanctions on Russia's oil exports. West Texas Intermediate crude for February delivery was last seen up US$2.95 to US$76.87 per barrel, the highest since Oct.7, while March Brent crude was up US$2.87 to US$79.79....

India's Infosys accuses rival Cognizant of anti-competitive practices

Jan 10, 2025

BENGALURU (Reuters) - India's Infosys filed a counterclaim against rival Cognizant in a Texas federal court on Thursday, accusing the U.S.-based firm of engaging in anti-competitive practices and poaching key executives. India's second-largest software company accused Cognizant of anti-competitive practices such as including clauses in contracts that stop clients from awarding IT services work to competitors and refusing them training...